RIKER LAUREN bought PCRX
February 11, 2026 · Form 4 insider transaction
RIKER LAUREN bought 19,273 shares of Pacira BioSciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
19,273
Price
$0.00
Total value
N/A
InsiderRIKER LAUREN
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 11, 2026
Filing dateFebruary 13, 2026
Shares owned after71,586
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units that vest in four equal annual installments beginning on February 15, 2027, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.